- Home
- HQI vs MIST Comparison
HQI vs MIST Comparison
Compare HQI & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HQI | MIST |
|---|---|---|
| Founded | 2002 | 2003 |
| Country | United States | Canada |
| Employees | 75000 | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.8M | 176.3M |
| IPO Year | 2008 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HQI | MIST |
|---|---|---|
| Price | $12.23 | $1.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $13.00 | $8.00 |
| AVG Volume (30 Days) | 16.2K | ★ 1.4M |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.08% | N/A |
| EPS Growth | ★ 73.08 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $30,640,000.00 | N/A |
| Revenue This Year | N/A | $2,915.14 |
| Revenue Next Year | $0.46 | N/A |
| P/E Ratio | $112.82 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.38 | $1.00 |
| 52 Week High | $13.19 | $3.06 |
Technical Indicators
Market Signals| Indicator | HQI | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 57.31 | 32.71 |
| Support Level | $9.92 | $1.47 |
| Resistance Level | $12.48 | $2.01 |
| Average True Range (ATR) | 0.79 | 0.12 |
| MACD | 0.07 | -0.06 |
| Stochastic Oscillator | 57.95 | 0.91 |
Price Performance
Historical ComparisonAbout HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).